Back
Direxion Daily Gold Miners Bull 2X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
57
NUGT
Direxion Daily Gold Miners Bull 2X ETF
Last Price:
45.62
Seasonality Move:
5.01%
Buy
61
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
56.79
Seasonality Move:
8.19%
Buy
57
Direxion Daily Gold Miners Bull 2X ETF (NUGT)
is a Buy
Is Direxion Daily Gold Miners Bull 2X ETF a Buy, Sell or Hold?
- The current Direxion Daily Gold Miners Bull 2X ETF [NUGT] share price is $45.56. The Score for NUGT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NUGT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Buy
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $57.05. The Score for BIB is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BIB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUGT Stock Price Chart
What is Direxion Daily Gold Miners Bull 2X ETF's stock price today?
-
The Direxion Daily Gold Miners Bull 2X ETF share price today is $45.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUGT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $57.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight selling pressure.
NUGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.91 | Buy |
Relative Strength Index (14 RSI): | 69.36 | Buy |
Chaikin Money Flow: | 2564384 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.38 - 41.96) | Buy |
Bollinger Bands (100): | (26.93 - 38.29) | Buy |
BIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.12 | Buy |
Relative Strength Index (14 RSI): | 61.94 | Buy |
Chaikin Money Flow: | -1686 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.48 - 55.88) | Buy |
Bollinger Bands (100): | (53.09 - 59.35) | Buy |
NUGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.28 | Buy |
20-day SMA: | 39.98 | Buy |
50-day SMA: | 36.84 | Buy |
200-day SMA: | 31.71 | Buy |
8-day EMA: | 42.49 | Buy |
20-day EMA: | 40.55 | Buy |
50-day EMA: | 37.32 | Buy |
200-day EMA: | 33.83 | Buy |
BIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.13 | Buy |
20-day SMA: | 53.6 | Buy |
50-day SMA: | 54.21 | Buy |
200-day SMA: | 52.17 | Buy |
8-day EMA: | 56.22 | Buy |
20-day EMA: | 54.69 | Buy |
50-day EMA: | 54.39 | Buy |
200-day EMA: | 53.76 | Buy |
Direxion Daily Gold Miners Bull 2X ETF Earnings Growth & NUGT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Gold Miners Bull 2X ETF Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |